DUBLIN
GC Aesthetics®, Inc. (GCA), a private medical technology company providing aesthetic and reconstructive solutions for women’s health, today announced its plans for growth and expansion into the Brazilian market, the second largest breast augmentation market in the world.
GC Aesthetics® has undertaken an ambitious journey to reposition the brand and portfolio to offer a smart, unique and clinically proven safe range of products that meet the needs of Brazilian women and surgeons.
The Brazilian growth strategy includes 2 main pillars: Firstly, the commercialization of all GC Aesthetics® products and solutions aimed at achieving the best possible outcome for women’s breast augmentation, namely before, during and after the operation. This unique portfolio not only differentiates itself from current industry competition, but also aligns with the company’s leadership position and growth plans as it has evolved from a breast implant manufacturer to a solutions provider.
The Brazilian sales growth of GC Aesthetics® is also linked to the ANVISA certification recently granted by the Brazilian Health Authority for the reintroduction of The Round Collection™ breast implants. This unique breast implant with a micro-textured surface is preferred by surgeons in Brazil: 99 % of plastic surgeons surveyed consider The Round Collection™ to be that most trustworthy product in relation to security and perfomance.
“According to our recent survey, long-term proven safety and unique microtexture are the top 2 reasons plastic surgeons in Brazil prefer The Round Collection implants over the competition. We are very happy to return to Brazil with this product and to offer surgeons and patients a proven, safe and reliable medical device. Pre-orders for this product have exceeded our projections and we look forward to a bright future as a leader in Brazil and the world.”so Carlos Reis Pinto, CEO von GC Aesthetics®.
“GCA® is dedicated to advancing the science of medical aesthetics and delivering exceptional clinical, operational and commercial services to establish itself as the partner of choice for surgeons and physicians around the world. We are excited to re-enter The Round Collection™ in Brazil and excited to present our brand as ONE GCA”said Ron Cosmas, CCO of GCA®.
GC Aesthetics® presents the reintroduction of this product at the Paulista Day of Plastic Surgery, the one from the 15th bis 18. im WTC Sao Paulo, Brasilien stattfindet. die Round Collection™ breast implants are engineered for performance with an unmatched long-term safety profile. The Round Collection™ by GC Aesthetics® is part of the largest long-term European clinical study for breast implants with excellent results after 10 years. Data from a unique 17-year follow-up study was recently published demonstrating remarkable patient satisfaction.
About GC Aesthetics
GC Aesthetics is a long-established, global medical technology company that develops, manufactures and markets a comprehensive line of proprietary aesthetic products that enable patients to feel confident and secure in their life journey.
For 40 years, GCA has been dedicated to advancing the science of aesthetic medicine and providing high quality breast implants for breast augmentation and reconstructive breast surgery. GCA is proud to have sold more than 3 million implants in 70 countries, with published 10-year clinical data supporting their safety and clinical efficacy.
The company’s vertically integrated strategy enables exceptional clinical, operational and commercial excellence that allows GCA to offer competitive products to physicians and patients. A culture of continuous innovation and customer commitment has established GCA as the leading provider of aesthetic medicine solutions and the partner of choice for patients looking to improve their lives.
The source language in which the original text is published is the official and authorized version. Translations will be included for a better understanding. Only the language version that was originally published is legally valid. Therefore, compare translations with the original language version of the publication.
View original version on businesswire.com: https://www.businesswire.com/news/home/20220615005654/de/
Fara Naomi Macias, Chief Marketing Officer
[email protected]
© Business Wire, Inc.
Notice of Use
This material is not editorial content of AFP. AFP is not responsible for the accuracy of the content. If you have any questions about the content of this notice, please contact the person named in the text.
–
